| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |